Cardiac Ventricular Thrombosis

Cardiac ventricular thrombosis is a serious condition where blood clots form inside the heart’s lower chambers, most commonly following a heart attack or in people with weakened heart muscle. While modern treatment methods have reduced how often this happens, it remains a significant risk that can lead to stroke and other life-threatening complications.

Table of contents

• What is cardiac ventricular thrombosis
• Location in the heart
• What causes blood clots in the heart
• Who is at risk
• Why this condition is dangerous
• How doctors find blood clots in the heart
• Treatment options
• How common is this condition

What is cardiac ventricular thrombosis

left ventricular thrombus, left ventricular thrombosis, LVT, intracardiac thrombosis

• Left ventricle
• Heart

Cardiac ventricular thrombosis refers to the formation of a blood clot (also called a thrombus) inside one of the heart’s lower chambers, called ventricles. Most commonly, these clots form in the left ventricle, which is the main pumping chamber of the heart^[1]. The clot is typically a mural thrombus, meaning it attaches to the wall of the ventricle^[2].

This condition is considered a serious complication that can occur after a heart attack (also called acute myocardial infarction or MI) or in people with certain types of heart muscle disease called cardiomyopathies^[1]. When heart tissue is damaged, conditions become favorable for blood clots to form in that area.

Location in the heart

Blood clots in the heart most often develop in the apex, which is the pointed bottom tip of the left ventricle^[1]. This location is particularly vulnerable because when the heart muscle is damaged, especially in this area, the normal movement of blood can become sluggish or stop altogether. The damaged tissue at the apex creates an environment where blood can pool and clot^[2].

What causes blood clots in the heart

Blood clots in the heart ventricle typically form most often during the first two weeks following a heart attack^[2]. The formation of these clots involves three main factors, known as Virchow’s triad^[2]:

First, when part of the heart muscle is damaged from a heart attack, that area may become akinetic (not moving) or dyskinetic (moving abnormally). This means blood flow in that area slows down or becomes stagnant. The larger the area of damage, the greater the risk that blood will pool and form clots^[2].

Second, the damaged heart tissue affects the inner lining of the heart called the endothelium. Normally, certain immune cells help clear away damaged tissue after a heart attack. Without proper clearing of this debris, the damaged tissue is exposed to flowing blood, which triggers the body to build a clot made of fibrin, red blood cells, and platelets as a protective response^[2].

Third, after a heart attack, the blood itself becomes more likely to clot. For several days following the event, levels of clotting factors in the blood remain elevated, which increases the risk of clot formation^[2].

Who is at risk

Several factors make it more likely that a person will develop a blood clot in the heart ventricle. People who have had a heart attack affecting the front wall of the heart (called an anterior MI) are at especially high risk^[1]. Other important risk factors include having the heart’s apex involved in the damage, regardless of which blood vessel was affected^[1].

Additional risk factors include having areas of the heart that don’t move properly (akinesis or dyskinesis), a reduced left ventricular ejection fraction (LVEF), which measures how well the heart pumps blood, severe problems with how the heart relaxes between beats (diastolic dysfunction), and having a large area of heart damage^[1].

The condition can also occur in people with heart muscle disease that is not caused by blocked arteries, known as non-ischemic cardiomyopathies^[1].

Why this condition is dangerous

The primary danger of having a blood clot in the heart ventricle is that the clot can break free and travel through the bloodstream, a process called cardiac embolism^[2]. When this happens, the traveling clot (called an embolus) can get stuck in blood vessels elsewhere in the body, blocking blood flow to vital organs.

Blockages can be especially damaging when they occur in the brain, causing a stroke, or in other organs like the spleen^[2]. People with blood clots in the heart face an increased risk of systemic embolism, stroke, cardiovascular events, and death^[1].

Doctors can sometimes predict whether a clot is likely to break free and travel by looking at certain characteristics during imaging tests. Clots that are mobile (moving with the blood flow) and those that stick out into the heart chamber (protrusion) are associated with a higher risk of becoming dangerous traveling clots^[2].

Interestingly, research suggests that the risk of clot-related complications may continue even after the clot appears to have dissolved. This means that people who have had a blood clot in the heart may need to continue treatment for a longer period than initially thought^[1].

How doctors find blood clots in the heart

Echocardiography, which uses sound waves to create images of the heart, is the main tool doctors use to detect blood clots in the heart. During this test, a distinct mass can be seen in the left ventricle^[2]. To improve the accuracy of detection, doctors may use special contrast agents during the ultrasound examination.

Cardiac magnetic resonance (CMR) imaging has the highest accuracy for detecting blood clots in the heart, followed by echocardiography when used with contrast agents^[1]. Other imaging methods like computed tomography (CT) and magnetic resonance imaging (MRI) can also detect these clots effectively, though they are used less commonly due to their costs and certain risks associated with the procedures^[2].

Treatment options

The main treatment for blood clots in the heart involves medications called anticoagulants, which help prevent the blood from clotting. This type of medication is considered the first-line medical therapy because it reduces the risk of the clot traveling to other parts of the body^[2].

After a heart attack, people at risk should receive treatment to prevent clot formation. This typically includes aspirin combined with an oral anticoagulant such as warfarin for individuals at risk of clot-related events^[2]. Current medical guidelines suggest using a vitamin K antagonist (VKA), like warfarin, for a minimum of three to six months^[1].

There is evidence that anticoagulant therapy for at least three months can reduce the risk of serious complications from these clots^[1]. Heparin, which is an injectable, fast-acting anticoagulant, can be effective in high doses for preventing clot formation after a heart attack^[2].

Growing evidence suggests that newer types of blood thinners called direct acting oral anticoagulants may also be beneficial in treating blood clots in the heart^[1]. However, more research through ongoing clinical trials is expected to help determine the best treatment strategies.

In some cases, surgical procedures may be performed to remove the clot directly, a procedure called thrombectomy. This approach has been used successfully in patients with large, mobile clots, sometimes performed at the same time as other heart procedures^[8].

How common is this condition

The rate of blood clot formation in the heart after a heart attack appears to be declining^[2]. This decrease is likely due to improvements in patient care, particularly better and earlier treatments to restore blood flow to the heart, known as reperfusion techniques^[1].

Before effective clot-dissolving treatments were available, this complication occurred in 20% to 60% of patients who had a heart attack^[5]. During the era when clot-dissolving medications became standard, the incidence dropped to about 5.1% overall, with higher rates (11.5%) in patients who had damage to the front wall of the heart^[5].

With modern treatment using procedures to open blocked arteries (percutaneous coronary intervention), the incidence has further decreased. Current estimates suggest that blood clots in the heart form in only about 2.5% to 15% of heart attack patients, with some studies reporting rates as low as 2.7% in patients treated with these modern procedures^[5][2].